NCT05670041

Re-hospitalisation After Transcatheter Aortic Valve Implantation

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Ole De Backer · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to investigate whether patient-tailored follow-up for patients treated with transcatheter aortic valve implantation (TAVI) can prevent re-hospitalisation and improve quality of life compared with the standard follow-up program. The rationale of this study is the persistently high rate of re-hospitalisation after TAVI, which increases the risk of mortality and diminishes the patient-evaluated quality of life. Our hypothesis is that patient-tailored follow-up for patients treated with TAVI will reduce the rate of re-hospitalisation after the TAVI-procedure and improve quality of life. The primary endpoints are the rate of re-hospitalisation within 90 days of the procedure and quality of life adjusted life years at 90-day follow-up.

Conditions

• Aortic Valve Disease
• Aortic Valve Stenosis

Interventions

Type	Name	Description
BEHAVIORAL	Intensified follow-up	Early, intensified follow-up after discharge from TAVI-procedure.

Timeline

• Start date: 2023-01-16
• Primary completion: 2024-03-16
• Completion: 2025-03-16
• First posted: 2023-01-04
• Last updated: 2023-09-07

Locations

1 site across 1 country: Denmark